Sephora Sackmann

Sephora Sackmann serves as Vice President at Cukierman & Co. Life Sciences since January 2022, following a progression from Senior Associate to Associate at Cukierman & Co. Investment House between June 2015 and December 2023. In these roles, Sephora Sackmann has provided assistance to various life sciences companies—including those in biotechnology, pharmaceuticals, diagnostics, medical devices, artificial intelligence, and digital health—in identifying, negotiating, and closing equity deals, venture debts, licensing agreements, strategic partnerships, and M&A transactions. Additionally, support has been extended to venture capital and private equity funds, private investors, family offices, and corporate development teams in evaluating and managing transactions across life sciences sectors. Prior experience includes roles as a Junior Analyst at Cukierman & Co. Investment House and a Business Analyst at Hewlett-Packard. Educational credentials include a Master of Science in Management with a focus on finance from Grenoble Ecole de Management and preparatory classes at Classe préparatoire Commercia.